High Plasma Phospholipid Transfer Protein Levels as a Risk Factor for Coronary Artery Disease
- 1 October 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (10), 1857-1862
- https://doi.org/10.1161/01.atv.0000094433.98445.7f
Abstract
Objective— Plasma phospholipid transfer protein (PLTP) mediates both net transfer and exchange of phospholipids between different lipoproteins. Animal studies have shown that it is closely related to the development of atherosclerosis. PLTP-deficient mice have demonstrated increased antioxidation potential as well as a decrease in apolipoprotein B secretion and atherosclerotic lesions. In humans, high PLTP is associated with type II diabetes and obesity. Methods and Results— To assess the relationship between PLTP activity and coronary artery disease (CAD), a novel, high-throughput method to measure plasma PLTP activity was used, relating it to CAD in 1102 cases and 444 controls. This demonstrated that PLTP activity in patients with CAD was significantly higher than in controls (25.5 versus 22.4 pmol/μL per h; P Conclusions— These findings indicate that PLTP activity is positively and independently related to CAD and suggest that (1) prospective studies to evaluate this relationship are warranted and (2) PLTP should be considered a therapeutic target.Keywords
This publication has 13 references indexed in Scilit:
- Phospholipid Transfer Protein Deficiency Protects Circulating Lipoproteins from Oxidation Due to the Enhanced Accumulation of Vitamin EJournal of Biological Chemistry, 2002
- Isolation and Partial Characterization of the Inactive and Active Forms of Human Plasma Phospholipid Transfer Protein (PLTP)Published by Elsevier ,2002
- Plasma phospholipid transfer protein activity in patients with low HDL and cardiovascular disease treated with simvastatin and niacinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2001
- Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiencyNature Medicine, 2001
- Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activityAtherosclerosis, 2000
- Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patientsDiabetologia, 1998
- PLASMA LIPID TRANSFER PROTEINS, HIGH-DENSITY LIPOPROTEINS, AND REVERSE CHOLESTEROL TRANSPORTAnnual Review of Nutrition, 1998
- Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.JCI Insight, 1996
- Reducing the risk of coronary events: Evidence from the Scandinavian Simvastatin survival study (4S)The American Journal of Cardiology, 1995
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989